63 results
424B5
RVMD
Revolution Medicines, Inc.
7 Aug 24
Prospectus supplement for primary offering
5:07pm
representing in the aggregate less than 1% of our outstanding shares.
EXPERTS
The financial statements and management’s assessment of the effectiveness … and management’s assessment of the effectiveness of internal control over financial reporting (which is included in Management’s annual report on internal control
S-3ASR
RVMD
Revolution Medicines, Inc.
8 May 24
Automatic shelf registration
5:11pm
The financial statements and management’s assessment of the effectiveness of internal control over financial reporting (which is included
S-3ASR
pmgb7xxiy2vh
4 Mar 24
Automatic shelf registration
5:23pm
425
m63rae 3hb
23 Oct 23
Business combination disclosure
6:13am
DEFM14A
7zf tvg0t
29 Sep 23
Proxy related to merger
4:19pm
424B3
c5ehn4440q013tildm
29 Sep 23
Prospectus supplement
4:17pm
S-4/A
si6zaehlwe2e w1zj8
27 Sep 23
Registration of securities issued in business combination transactions (amended)
5:25pm
S-4
naoj3xgbdtw
13 Sep 23
Registration of securities issued in business combination transactions
5:20pm
425
ug0mrf
1 Aug 23
Business combination disclosure
5:24pm
425
y1yxh3u
1 Aug 23
Business combination disclosure
5:22pm
425
yrwmktpslgucs8n7i5n
1 Aug 23
Business combination disclosure
5:11pm
425
0hkzpejd
1 Aug 23
Business combination disclosure
7:15am
8-K
EX-2.1
gpk0l ftt308ae0ndz
1 Aug 23
Form of Parent Stockholder Voting Agreement
7:10am